Corrigendum to "Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials", [Urol Sci, (2015), 41-48], doi:10.1016/j.urols.2014.12.010

Kuo H.-C.HO-HSIUNG LINHONG-JENG YUCheng C.-L.Hung M.-J.Lin A.T.L.Chang C.-H.Chuang Y.-C.Cha T.-L.Chen G.-D.Chen C.-S.Wu M.-P.Wu T.-L.Yu K.-J.Huang S.-T.The Taiwan Mirabegron Study Team2021-02-022021-02-0220151879-5226https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937423766&doi=10.1016%2fj.urols.2015.06.290&partnerID=40&md5=74aa1b70781d1a3fde877911e344d509https://scholars.lib.ntu.edu.tw/handle/123456789/544123Corrigendum to "Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials", [Urol Sci, (2015), 41-48], doi:10.1016/j.urols.2014.12.010corrigendum10.1016/j.urols.2015.06.2902-s2.0-84937423766